Article

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer

2021-02-02

Abstract excerpt

<title>Abstract</title> <p>Cancer patients have increased morbidity and mortality from Coronavirus Disease 2019 (COVID-19), but the underlying immune mechanisms are unknown. In a cohort of 100 cancer patients hospitalized for COVID-19 at the University of Pennsylvania Health System, we found that patients with hematologic cancers had a significantly higher mortality relative to patients with solid cancers after a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ac653b54-4d25-5b97-a17f-71f9ed32c8e4
DOI: 10.21203/rs.3.rs-162289/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerDOI 10.21203/rs.3.rs-162289/v1Read

Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patientsSemantic proximity Read

SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapiesSemantic proximity Read

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraSemantic proximity Read

Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trialSemantic proximity Read

Immunophenotyping for Risk Stratification of Patients with COVID-19Semantic proximity Read

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studySemantic proximity Read

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studySemantic proximity Read

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlightsSemantic proximity Read

Immune targeted therapies for COVID-19 Infection: A Promising OutlookSemantic proximity Read

Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccinationSemantic proximity Read

Epithelial galectin-3 induces mitochondrial complex inhibition and cell cycle arrest of CD8 <sup>+</sup> T Cells in severe/critical ill COVID-19Semantic proximity Read

How does SARS‐CoV‐2 infection impact on immunity, procession and treatment of pan cancersSemantic proximity Read